Literature DB >> 26333369

Discontinuation of P2Y12 antagonists before coronary bypass surgery: is 5 days really required?

Franz Weidinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26333369     DOI： 10.1093/eurheartj/ehv469

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  Clopidogrel Therapy in Patients with Cardiovascular Disease Undergoing Transurethral Resection of the Prostate: A Step Towards Individualization.

Authors:  Petros Tzimas; Maria Tsoumani; Dimitrios Giannakis; Kallirroi Kalantzi; Anastasios Petrou; Vasileios Chantzichristos; Nikolaos Sofikitis; Georgios Papadopoulos; Haralampos Milionis; Alexandros Tselepis
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

2.  Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes.

Authors:  Sammer Diab; Shemy Carasso; Mattan Arazi; Leonid Sternik; Ehud Raanani; Erez Kachel; Liza Grosman-Rimon; Amjad Shalabi; Offer Amir
Journal:  J Cardiothorac Surg       Date:  2021-05-22       Impact factor: 1.637

3.  Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery.

Authors:  Bright Huo; Gregory M Hirsch; Steve Doucette; Christine R Herman; Ryan Gainer; Ahmed T Mokhtar
Journal:  CJC Open       Date:  2021-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.